Target intelligence / Profile preview

Ligand-dependent nuclear receptor-interacting factor 1 (LRIF1)

Target
LRIF1
Molecular classification
Other, Chromatin regulator, Nuclear matrix-associated protein
01

Overview

Ligand-dependent nuclear receptor-interacting factor 1 (LRIF1) is a nuclear protein that functions as a chromatin regulator, contributing to chromatin organization, epigenetic gene silencing, and chromosome segregation during mitosis[1][2][4]. LRIF1 recruits Heterochromatin protein 1 alpha (HP1α) to the centromere via a conserved PXVXL motif, a process essential for accurate chromosome alignment and segregation during cell division[1]. It also plays a role in dosage compensation through X chromosome inactivation by collaborating with SMCHD1, compacts heterochromatin, and suppresses gene expression from loci such as DUX4[2][3]. Mutations in the LRIF1 gene are associated with facioscapulohumeral muscular dystrophy type 3 (FSHD3) and its protein product interacts with the nuclear retinoic acid receptor and other chromatin-associated regulators[2][3][4]. LRIF1 is not a receptor, enzyme, transporter, or typical therapeutic target, and currently, there are no known drugs or clinical biomarkers associated with it[2][4].

Other names
C1orf103RIF1FLJ11269HBiX1FSHD3HP1-binding protein enriched in inactive X chromosome protein 1Receptor-interacting factor 1
02

Biological functions

Chromatin organizationCentromere functionEpigenetic gene silencingDosage compensationX chromosome inactivationRegulation of mitosis
03

Disease associations

Facioscapulohumeral muscular dystrophy (FSHD3)Musculoskeletal disorders

Beyond the preview

Go deeper on Ligand-dependent nuclear receptor-interacting factor 1 (LRIF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ligand-dependent nuclear receptor-interacting factor 1 (LRIF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call